HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

NeurologyLive Friday 5 — September 3, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 3, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: NeurologyLive Top Expert Interviews: August 2021

A number of expert clinicians offered their perspectives to NeurologyLive in the month of August, detailing their thoughts on the upcoming IFN 2021 Congress, the impact of aducanumab's approval, treating optic neuritis in NMOSD, research into cranial neuralgias, and the development of miniature AD brain models.

2: Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

On behalf of the advocacy organization Cure SMA, Elanda Williams, MA; Mary Schroth, MD, FAAP, FCCP; and Alesa Monk, MBA, provide insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in spinal muscular atrophy.

3: NeuroVoices: Sean Pittock, MD, on Improving Treatment Optimization, Clinical Pipeline of NMOSD

The director of the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology discussed unmet needs of care for patients with neuromyelitis optica spectrum disorder, providing context on the recent advances within the field, areas that still need to be addressed, and mechanisms that have high potential to target.

4: Dementia Research in Multicultural Communities: James E. Galvin, MD, MPH

The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed projects dedicated to improving dementia recognition and care within multicultural communities—noting the importance of bringing the tools to the patients in their communities.

5: Access to Pediatric Rehab Therapies Affected Well-Being During COVID-19 Pandemic

Investigators concluded that feedback from children with motor impairment and their caregivers should be incorporated as telehealth continues to be integrated into daily clinical care, as these populations experienced interrupted access to rehabilitation therapies during the COVID-19 pandemic.

——————————————————

The 3rd Annual International Congress on the Future of Neurology® is coming up! The virtual meeting, which will showcase the most recent advancements in neurologic disorders, is being held September 17-18, 2021. The target audience for this activity is physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.

The learning objectives of the program are:

  • Outline current and emerging diagnostic concepts for neurologic disorders
  • Explain clinical evidence for the management of neurologic disorders across multiple lines of care
  • Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
  • Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies
  • Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
  • Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology